[Targeting Ca(v)3.2 T-type calcium channels as a therapeutic strategy for chemotherapy-induced neuropathic pain]

Nihon Yakurigaku Zasshi. 2013 Feb;141(2):81-4. doi: 10.1254/fpj.141.81.
[Article in Japanese]
No abstract available

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects*
  • Ascorbic Acid / pharmacology
  • Calcium Channels, T-Type / drug effects*
  • Calcium Channels, T-Type / physiology
  • Dinoprostone / pharmacology
  • Humans
  • Hydrogen Sulfide / pharmacology
  • Molecular Targeted Therapy
  • Neuralgia / chemically induced*
  • Neuralgia / drug therapy*
  • Paclitaxel / adverse effects
  • Peripheral Nervous System Diseases / chemically induced
  • Peripheral Nervous System Diseases / drug therapy

Substances

  • Antineoplastic Agents
  • Calcium Channels, T-Type
  • Dinoprostone
  • Paclitaxel
  • Ascorbic Acid
  • Hydrogen Sulfide